CompletedPhase 4

Chlorhydrate of Ropivacaine and Breast Cancer Surgery

France260 participantsStarted 2006-09

Plain-language summary

The aim of the study is to evaluate the effect of local anesthetic (chlorhydrate of ropivacaine) to prevent chronic pain after breast surgery for cancer.

Who can participate

Age range18 Years – 85 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Breast cancer patients treated by conservative surgery with axillary node dissection or treated by mastectomy with or without axillary node dissection or sentinel lymph node biopsy. * ASA physical status 1, 2 or 3 * With a minimum life expectancy of 2 years * Written informed consent Exclusion Criteria: * Any previous cancer other than breast cancer * Allergies to local anesthesic and morphine * Reported history of drug * Pregnancy * Homolateral breast surgery during the last 3 years * Analgesic use pre-operatively * Renal, pulmonary or liver major dysfunction * Active malignant disease * Unable to follow the protocol for any reason

What they're measuring

Comparing the frequencies of chronic breast pain 3 months after breast surgery evaluated by the Brief Pain Inventory in the two groups.

Timeframe: 3 months after surgery

Trial details

NCT IDNCT00370240

SponsorInstitut Curie

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2007-07

View on ClinicalTrials.gov More Breast Neoplasms trials